Serum prolidase Activity in Ankylosing spondylitis and Rheumatoid Arthritis

被引:14
作者
Ucar, Demet [1 ]
Em, Serda [1 ]
Bozkurt, Mehtap [1 ]
Oktayoglu, Pelin [1 ]
Yuksel, Hatice Kurt [2 ]
Caglayan, Mehmet [1 ]
Gezer, Orhan [1 ]
Nas, Kemal [1 ]
机构
[1] Dicle Univ, Med Fac, Dept Phys Med & Rehabil, Diyarbakir, Turkey
[2] Dicle Univ Med Fac, Dept Biochem, Diyarbakir, Turkey
关键词
ankylosing spondylitis; rheumatoid arthritis; serum prolidase activity;
D O I
10.4137/CMAMD.S12602
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The aim of the present study was to emphasize the collagen turnover in 2 of the most common chronic inflammatory rheumatic diseases by evaluating serum prolidase activity (SPA) in ankylosing spondylitis (AS) and rheumatoid arthritis (RA). 30 patients who met the modified New York Criteria for the classification of AS, 29 patients who met the 2010 Rheumatoid Arthritis Classification Criteria for the classification of RA, and 31 healthy controls were enrolled in the study. Serum samples of the patients and the controls were collected and SPA was measured by a spectrophotometric method. The comparison of the SPA in these 3 groups was statistically examined. In both patient groups, the SPA was lower than in the control group. SPA in patients with AS was statistically significantly lower than in the control and RA groups (P, 0.001/P = 0.002). No statistically significant difference was found between the RA and the control groups (P = 0.891). In conclusion, lower SPA is presumably associated with decreased collagen turnover and fibrosis, leading to decreased physical functions in both chronic inflammatory musculoskeletal diseases.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 20 条
[1]   2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative [J].
Aletaha, Daniel ;
Neogi, Tuhina ;
Silman, Alan J. ;
Funovits, Julia ;
Felson, David T. ;
Bingham, Clifton O., III ;
Birnbaum, Neal S. ;
Burmester, Gerd R. ;
Bykerk, Vivian P. ;
Cohen, Marc D. ;
Combe, Bernard ;
Costenbader, Karen H. ;
Dougados, Maxime ;
Emery, Paul ;
Ferraccioli, Gianfranco ;
Hazes, Johanna M. W. ;
Hobbs, Kathryn ;
Huizinga, Tom W. J. ;
Kavanaugh, Arthur ;
Kay, Jonathan ;
Kvien, Tore K. ;
Laing, Timothy ;
Mease, Philip ;
Menard, Henri A. ;
Moreland, Larry W. ;
Naden, Raymond L. ;
Pincus, Theodore ;
Smolen, Josef S. ;
Stanislawska-Biernat, Ewa ;
Symmons, Deborah ;
Tak, Paul P. ;
Upchurch, Katherine S. ;
Vencovsky, Jiri ;
Wolfe, Frederick ;
Hawker, Gillian .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2569-2581
[2]   Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis [J].
Altindag, Ozlem ;
Erel, Ozcan ;
Aksoy, Nurten ;
Selek, Sahabettin ;
Celik, Hakim ;
Karaoglanoglu, Mustafa .
RHEUMATOLOGY INTERNATIONAL, 2007, 27 (04) :339-344
[3]   PROLIDASE DEFICIENCY - DERMATOLOGICAL MANIFESTATIONS AND SOME ADDITIONAL BIOCHEMICAL STUDIES [J].
ARATA, J ;
UMEMURA, S ;
YAMAMOTO, Y ;
HAGIYAMA, M ;
NOHARA, N .
ARCHIVES OF DERMATOLOGY, 1979, 115 (01) :62-67
[4]  
BUTBUL AY, 2012, PEDIAT RHEUMATOL ONL, V10, P18, DOI DOI 10.1186/1546-0096-10-18
[5]   Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study [J].
Dischereit, Gabriel ;
Tarner, Ingo H. ;
Mueller-Ladner, Ulf ;
Lange, Uwe .
CLINICAL RHEUMATOLOGY, 2013, 32 (03) :377-381
[6]   Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus [J].
Erbagci, AB ;
Araz, M ;
Erbagci, A ;
Tarakçioglu, M ;
Namiduru, ES .
CLINICAL BIOCHEMISTRY, 2002, 35 (04) :263-268
[7]   GENERALIZED BONE LOSS IN PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS [J].
GOUGH, AKS ;
LILLEY, J ;
EYRE, S ;
HOLDER, RL ;
EMERY, P .
LANCET, 1994, 344 (8914) :23-27
[8]   PROLIDASE ACTIVITY IN BRAIN - COMPARISON WITH OTHER ORGANS [J].
HUI, KS ;
LAJTHA, A .
JOURNAL OF NEUROCHEMISTRY, 1978, 30 (02) :321-327
[9]  
Landewe R, 2009, CLIN EXP RHEUMATOL, V27, pS102
[10]  
Lories RJ, 2009, CLIN EXP RHEUMATOL, V27, pS10